Holding(s) in Company

RNS Number : 6554J

Allergy Therapeutics PLC

08 April 2015

 



For filings with the FCA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii				Allergy Therapeutics Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights					Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached					No
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments					No
An event changing the breakdown of voting rights					No
Other (please specify):					No
3. Full name of person(s) subject to the notification obligation: iii		Invesco Limited
4. Full name of shareholder(s)  (if different from 3.):iv
5. Date of the transaction and date on which the threshold is crossed or reached: v		31 March 2015
6. Date on which issuer notified:		01 April 2015
7. Threshold(s) that is/are crossed or reached: vi, vii		5%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B02LCQ05

18,016,209

18,016,209

30,685,209

5.62%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

30,685,209

5.62%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Invesco Asset Management Limited - 30,685,209
Proxy Voting:
10. Name of the proxy holder:		Invesco Limited
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A
13. Additional information:
14. Contact name:	Philippa Sadler
15. Contact telephone number:	01491 417 447

Note: Annex should only be submitted to the FCA not the issuer
Annex: Notification of major interests in sharesxxii
A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)
Contact address (registered office for legal entities)
Phone number & email
Other useful information (at least legal representative for legal persons)
B: Identity of the notifier, if applicable
Full name	Invesco (UK) Limited
Contact address	Perpetual Park, Perpetual Park Drive, Henley-on-Thames. Oxon. RG9 1HH
Phone number & email	01491 417 000
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)	Invesco (UK) Limited
C: Additional information
For notes on how to complete form TR-1 please see the FCA website.

 

END

 

 

HOLUWSSRVBASRAR